» Articles » PMID: 30341553

Blockade of Rapid Influx of Extracellular Zn into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats

Overview
Journal Mol Neurobiol
Date 2018 Oct 21
PMID 30341553
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The herbicide paraquat (PQ) has been reported to enhance the risk of developing Parkinson's disease (PD) from epidemiological studies. PQ-induced reactive oxygen species (ROS) are linked with a selective loss of nigrostriatal dopaminergic neurons. Here, we first report a unique mechanism of nigrostriatal dopaminergic degeneration, in which rapid intracellular Zn dysregulation via PQ-induced ROS production causes PD in rats. When the substantia nigra pars compacta (SNpc) of rats was perfused with PQ, extracellular concentrations of glutamate and Zn were increased and decreased, respectively, in the SNpc. These changes were ameliorated by co-perfusion with Trolox, an antioxidative agent. In in vitro slice experiments, PQ rapidly increased extracellular Zn influx via AMPA receptor activation. Both loss of nigrostriatal dopaminergic neurons and increase in turning behavior in response to apomorphine were markedly reduced by coinjection of PQ and intracellular Zn chelator, i.e., ZnAF-2DA into the SNpc. Furthermore, loss of nigrostriatal dopaminergic neurons induced with a low dose of PQ, which did not induce any behavioral abnormality, was completely blocked by coinjection of ZnAF-2DA. The present study indicates that rapid influx of extracellular Zn into dopaminergic neurons via AMPA receptor activation, which is initially induced by PQ-mediated ROS production in the SNpc, induces nigrostriatal dopaminergic degeneration, resulting in PQ-induced PD in rats. Intracellular Zn dysregulation in dopaminergic neurons is the cause of PQ-induced pathogenesis in the SNpc, and the block of intracellular Zn toxicity leads to defending PQ-induced pathogenesis.

Citing Articles

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


The Role of Zinc in the Development of Vascular Dementia and Parkinson's Disease and the Potential of Carnosine as Their Therapeutic Agent.

Mizuno D, Kawahara M, Konoha-Mizuno K, Hama R, Ogawara T Biomedicines. 2024; 12(6).

PMID: 38927502 PMC: 11201809. DOI: 10.3390/biomedicines12061296.


Dopamine Activates the D1R-Zn Signaling Pathway to Trigger Inflammatory Response in Primary-Cultured Rat Embryonic Cortical Neurons.

Tseng H, Pan C Cell Mol Neurobiol. 2023; 43(7):3593-3604.

PMID: 37289255 PMC: 11409952. DOI: 10.1007/s10571-023-01367-z.


Zinc Homeostasis: An Emerging Therapeutic Target for Neuroinflammation Related Diseases.

Liu S, Wang N, Long Y, Wu Z, Zhou S Biomolecules. 2023; 13(3).

PMID: 36979351 PMC: 10046788. DOI: 10.3390/biom13030416.


Zinc.

Skalny A, Aschner M, Tinkov A Adv Food Nutr Res. 2021; 96:251-310.

PMID: 34112355 PMC: 8208231. DOI: 10.1016/bs.afnr.2021.01.003.


References
1.
de Lau L, Breteler M . Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5(6):525-35. DOI: 10.1016/S1474-4422(06)70471-9. View

2.
Zhang L, Dawson V, Dawson T . Role of nitric oxide in Parkinson's disease. Pharmacol Ther. 2005; 109(1-2):33-41. DOI: 10.1016/j.pharmthera.2005.05.007. View

3.
Pochwat B, Nowak G, Szewczyk B . Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying Neurodegeneration. Neural Plast. 2015; 2015:591563. PMC: 4461779. DOI: 10.1155/2015/591563. View

4.
Frederickson C, Koh J, Bush A . The neurobiology of zinc in health and disease. Nat Rev Neurosci. 2005; 6(6):449-62. DOI: 10.1038/nrn1671. View

5.
Takeda A, Tamano H, Hisatsune M, Murakami T, Nakada H, Fujii H . Maintained LTP and Memory Are Lost by Zn Influx into Dentate Granule Cells, but Not Ca Influx. Mol Neurobiol. 2017; 55(2):1498-1508. DOI: 10.1007/s12035-017-0428-3. View